Clinical trial
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines…
NCT00319592 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00319592 |
|---|---|
| Title | A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX |
| Official title | Randomized, Double-blind, Phase II Study of the Safety, Tolerability and Immunogenicity Following Administration of Live Attenuated JE Vaccine (ChimeriVax™ JE) Compared With Mouse Brain-derived Inactivated JE Vaccine (JE VAX®). |
| Lead sponsor | Sanofi, Industry |
| Collaborators | PRA Health Sciences Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Japanese Encephalitis |
| Intervention type | Biological |
| Interventions | ChimeriVax™-JE vaccine, JE-VAX® vaccine |
| Enrollment | 60 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Aug 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: